Vaxdyn introduces its multi-pathogen vaccine candidate KapaVax at the World Vaccine Congress Europe

SEVILLE, SPAIN – In an oral presentation within the track “AMR & Bacterial Vaccines”, chaired by Dr Jan Poolman (Bacterial Vaccine Discovery and Early Development, Janssen), Dr. Infante showed how Vaxdyn’s technology can deliver endotoxin-free inactivated whole cell vaccines presenting outer-membrane proteins of different bacteria in the surface, therefore raising immunity against different bacteria with only one immunogen. The KapaVax candidate targets include three of the most worrisome antibiotic-resistant bacteria of the list of the WHO: Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter baumannii, for which there are not available vaccines yet. The primary target population in need will be individuals affected by chronic lung problems in high risk of developing antibiotic-resistant infections by these bacteria.

The presentation of Dr. Infante was part of a session of pipeline updates by companies funded by the CARB-X organization (Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator;, moderated by CARB-X Alliance Director Dr. Ed T. Buurman and with participation of other two institutions of CARB-X’s pipeline, Vaxcyte, presented by Dr. Jeff Fairman (VP of Research), and The Jenner Institute, presented by Dr. Calman MacLennan (Professor of Vaccine Immunology).

About Vaxdyn S.L.

Vaxdyn is dedicated to improving quality of life in populations affected by infections globally. Vaxdyn’s vision is to create specific immunity in high-risk populations against the most antibiotic resistant bacterial pathogens. Headquartered in Seville, Spain, Vaxdyn works with an international network of collaborators in the development of multi-pathogen vaccines for preventing infections in individuals affected by chronic diseases of the lungs, liver, kidney, immunocompromised by several co-morbidities such as diabetes or cancer, and populations associated with nursing homes and hospital settings. Vaxdyn is strongly committed to contribute to reducing antibiotic use in the world by following a One-Health approach.

About World Vaccine Congress

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe.

CEO Contact

Juan José Infante

[email protected]

Media Contact

María Teresa Díaz

[email protected]